Drug Company Recalls Metoprolol Over Foreign Tablets

Thousands of bottles of a high blood pressure and heart drug are recalled nationwide after foreign tablets or capsules were found in the product.

Updated on Nov. 11, 2026 in Heart Disease

Isometric editorial illustration of a row of plain amber medicine bottles with white caps and loose tablets, set on a pale surface, evoking a nationwide heart-medication recall.
Drug company recalls thousands of bottles of metoprolol nationwide on Oct. 27 after foreign tablets or capsules were found in the product. AI Illustration. Upload story photo >

Live Poll

Do you trust that medications recalled for contamination are still safe to keep taking?

A New Jersey-based drug company is recalling thousands of bottles of metoprolol, a high blood pressure and heart medication, because foreign tablets or capsules were found in the product. The recall was initiated on Oct. 27, 2026, and the tablets were distributed around the United States.

Why it matters

Metoprolol is widely prescribed for heart and blood pressure conditions, so patients holding the affected batch may need to check their supply. The recall highlights how contamination in common cardiac medications can reach patients across the country.

The recalled batch is number 2611C065A1 with an May 2028 expiration date, and the FDA has classified the action as class II. The notice does not disclose the identity or composition of the foreign material or how it entered the product.

The players

Food and Drug Administration (FDA)

The U.S. federal agency responsible for regulating drug safety, which classified this recall as class II and published it in its weekly enforcement report.

The details

The drug company notified customers of the recall by letter, and the FDA included the notice in its weekly enforcement report on Nov. 11. The recall covers thousands of bottles distributed nationwide, and the company has not publicly explained the source of the contamination.

Timeline

  1. Oct. 27, 2026: Recall initiated and customers notified by letter.

  2. Nov. 11, 2026: FDA classifies recall as class II and publishes it in its weekly enforcement report.

  3. May 2028: Expiration date of the recalled batch.

Recall Context

Under the FDA's three-tier classification system, class II recalls cover products that may cause temporary or medically reversible health problems, which places this metoprolol action between the most serious class I and the least serious class III. Contamination reports like this one appear regularly in the agency's weekly enforcement reports, which track recalls across the nation's drug supply.

Patients taking metoprolol should check their bottle for batch number 2611C065A1 and expiration date of May 2028 and contact their pharmacy or prescriber before stopping the medication. Stopping a heart or blood pressure drug without medical guidance can be risky, so any replacement should be arranged with a healthcare provider.

The takeaway

Checking the batch number on any recalled prescription bottle is a simple step that helps patients avoid contaminated medication. Reviewing the FDA's weekly enforcement reports can also keep patients and caregivers informed about recalls affecting their prescriptions.

Further reading

For more on the medications used to treat these conditions, see Heart Disease.

Source note: This article includes information reported by Theepochtimes.

Live Poll

Do you trust that medications recalled for contamination are still safe to keep taking?